Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 EUR | +0.72% | -2.44% | +25.56% |
04-26 | Unibios Holdings S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Unibios Holdings S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 1.019 | 1.313 | 4.443 | 9.338 | 10.58 | 18.91 |
Enterprise Value (EV) 1 | 9.77 | 8.021 | 10.82 | 14.55 | 18.63 | 22.14 |
P/E ratio | -2.58 x | 28.2 x | -48.3 x | 28.1 x | 16.4 x | 9.37 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.13 x | 0.16 x | 0.61 x | 1.1 x | 0.94 x | 1.46 x |
EV / Revenue | 1.22 x | 0.96 x | 1.48 x | 1.72 x | 1.66 x | 1.71 x |
EV / EBITDA | 17.4 x | 7.71 x | 15.9 x | 14.7 x | 11.3 x | 6.47 x |
EV / FCF | -10.8 x | -10.7 x | 78.9 x | 12.8 x | -7.85 x | 15.8 x |
FCF Yield | -9.23% | -9.38% | 1.27% | 7.84% | -12.7% | 6.33% |
Price to Book | 0.13 x | 0.56 x | 0.38 x | 0.73 x | 0.85 x | 1.31 x |
Nbr of stocks (in thousands) | 3,107 | 3,105 | 15,590 | 15,564 | 15,511 | 16,957 |
Reference price 2 | 0.3280 | 0.4230 | 0.2850 | 0.6000 | 0.6820 | 1.115 |
Announcement Date | 19-04-24 | 20-05-28 | 21-04-28 | 22-04-20 | 23-04-30 | 24-04-26 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 7.983 | 8.34 | 7.3 | 8.478 | 11.24 | 12.98 |
EBITDA 1 | 0.5623 | 1.04 | 0.6825 | 0.991 | 1.647 | 3.423 |
EBIT 1 | 0.2956 | 0.7352 | 0.4206 | 0.7228 | 1.339 | 3.026 |
Operating Margin | 3.7% | 8.82% | 5.76% | 8.53% | 11.91% | 23.32% |
Earnings before Tax (EBT) 1 | -0.2037 | 0.3046 | 0.0412 | 0.5516 | 0.9976 | 2.402 |
Net income 1 | -0.3973 | 0.1004 | -0.0922 | 0.3339 | 0.6506 | 2.028 |
Net margin | -4.98% | 1.2% | -1.26% | 3.94% | 5.79% | 15.63% |
EPS 2 | -0.1271 | 0.0150 | -0.005898 | 0.0214 | 0.0416 | 0.1190 |
Free Cash Flow 1 | -0.9013 | -0.7526 | 0.1371 | 1.141 | -2.374 | 1.402 |
FCF margin | -11.29% | -9.02% | 1.88% | 13.46% | -21.11% | 10.8% |
FCF Conversion (EBITDA) | - | - | 20.09% | 115.14% | - | 40.95% |
FCF Conversion (Net income) | - | - | - | 341.74% | - | 69.12% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-24 | 20-05-28 | 21-04-28 | 22-04-20 | 23-04-30 | 24-04-26 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 8.75 | 6.71 | 6.38 | 5.22 | 8.05 | 3.23 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 15.56 x | 6.45 x | 9.35 x | 5.262 x | 4.885 x | 0.9446 x |
Free Cash Flow 1 | -0.9 | -0.75 | 0.14 | 1.14 | -2.37 | 1.4 |
ROE (net income / shareholders' equity) | -3.85% | 1% | -0.78% | 2.71% | 4.92% | 13.9% |
ROA (Net income/ Total Assets) | 0.93% | 2.19% | 1.18% | 1.94% | 3.38% | 7.24% |
Assets 1 | -42.69 | 4.588 | -7.84 | 17.23 | 19.24 | 28.02 |
Book Value Per Share 2 | 2.610 | 0.7600 | 0.7500 | 0.8300 | 0.8000 | 0.8500 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0800 | 0.0900 | 0.0200 | 0.1600 |
Capex 1 | 0.23 | 0.3 | 0.06 | 0.05 | 0.38 | 0.16 |
Capex / Sales | 2.85% | 3.58% | 0.86% | 0.58% | 3.41% | 1.22% |
Announcement Date | 19-04-24 | 20-05-28 | 21-04-28 | 22-04-20 | 23-04-30 | 24-04-26 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+25.56% | 25.81M | |
+26.06% | 139B | |
+37.13% | 132B | |
+15.98% | 64.57B | |
+1.16% | 38.61B | |
+101.56% | 36.24B | |
+7.40% | 32.53B | |
-13.12% | 30.75B | |
+7.44% | 28.73B | |
+28.66% | 27.09B |
- Stock Market
- Equities
- BIOSK Stock
- Financials Unibios Holdings S.A.